Occurrence of the diffuse amyloid β‐protein (Aβ) deposits with numerous Aβ‐containing glial cells in the cerebral cortex of patients with Alzheimer's disease

Diffuse amyloid β‐protein (Aβ) deposits with numerous glial cells containing C‐terminal Aβ fragments occur in the cerebral cortex of patients with Alzheimer's disease. By using a panel of antibodies specific for various epitopes in the Aβ peptide, we have investigated the immunohistochemical nature of the diffuse Aβ deposits. The extracellular material contains Aβ with a C‐terminus at residue valine40 (Aβ40) as well as residues alanine42/threonine43 (Aβ42). The N‐termini include aspartate1, pyroglutamate3, and pyroglutamate11, with pyroglutamate3 being dominant. Microglia and astrocytes in and around these deposits contain intensely staining granules. Most of these granules are negative for antibodies to the N‐terminally located sequences of Aβ. These include 6E10 (Aβ1–17), 6F/3D (Aβ8–17), and the N‐terminal antibodies specific to aspartate1, pyroglutamate3, and pyroglutamate11. The C‐termini of intraglial Aβ are comparable with those of the extracellular deposits. The microglia and astrocytes have quiescent morphology compared with those associated with senile plaques and other lesions such as ischemia. Complement activation in these deposits is not prominent and often below the sensitivity of immunohistochemical detection. Although factors which may cause this type of deposit remain unclear, lack of strong tissue responses suggests that these deposits are a very early stage of Aβ deposition. They were found only inconsistently and were absent in a number of cases examined in this study. Further analysis of these deposits might provide important clues regarding the accumulation and clearance of Aβ in Alzheimer's disease brain. GLIA 25:324–331, 1999. © 1999 Wiley‐Liss, Inc.

[1]  D. Selkoe,et al.  Degradation of Amyloid β-Protein by a Metalloprotease Secreted by Microglia and Other Neural and Non-neural Cells* , 1997, The Journal of Biological Chemistry.

[2]  L. Mucke,et al.  β-Secretase Processing of the β-Amyloid Precursor Protein in Transgenic Mice Is Efficient in Neurons but Inefficient in Astrocytes* , 1996, The Journal of Biological Chemistry.

[3]  J. Trojanowski,et al.  Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. , 1996, The American journal of pathology.

[4]  Masanori Kato,et al.  The amino-terminally truncated forms of amyloid β-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients , 1996, Neuroscience Letters.

[5]  T. Iwatsubo,et al.  Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain , 1996, Neuroscience Letters.

[6]  F. Maxfield,et al.  Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.

[7]  R. Xue,et al.  Amyloid Precursor Protein Metabolism in Primary Cell Cultures of Neurons, Astrocytes, and Microglia , 1996, Journal of neurochemistry.

[8]  R. Ihl,et al.  Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques. , 1996, The American journal of pathology.

[9]  P. Mcgeer,et al.  Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein , 1996, Neuroscience Letters.

[10]  B. Strooper,et al.  Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  G. Cole,et al.  Scavenging of Alzheimer's amyloid β‐protein by microglia in culture , 1996, Journal of neuroscience research.

[12]  S. Younkin,et al.  Amyloid β protein (Aβ) removal by neuroglial cells in culture , 1995, Neurobiology of Aging.

[13]  A. Odaka,et al.  Amyloid β protein 1–42/43 (Aβ 1–42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study , 1995, Brain Research.

[14]  D. Mann,et al.  Dominant and differential deposition of distinct β-amyloid peptide species, Aβ N3(pE), in senile plaques , 1995, Neuron.

[15]  D. Quon,et al.  -Amyloid Peptide Produced in Vitro Is Degraded by Proteinases Released by Cultured Cells (*) , 1995, The Journal of Biological Chemistry.

[16]  P. Greengard,et al.  Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[18]  P. Mcgeer,et al.  Expression of MRP14, 27E10, interferon-α and leukocyte common antigen by reactive microglia in postmortem human brain tissue , 1994, Journal of Neuroimmunology.

[19]  I. Tooyama,et al.  Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease , 1993, Brain Research.

[20]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[21]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[22]  D. Selkoe,et al.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.

[23]  H. Vinters,et al.  Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Burger,et al.  Macrophage Markers in Diagnostic Neuropathology , 1992, The American journal of surgical pathology.

[25]  P. Mcgeer,et al.  Brain microglia constitutively express β-2 integrins , 1990, Journal of Neuroimmunology.

[26]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[27]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.